TP Pivot Pro™ Transperineal Biopsy Needle Guide

TP Pivot Pro

• Using transperineal prostate biopsy technique, infectious complications are nullified due to avoidance of needle passage through rectal mucosa, and there is highly significant evidence of reduced fever and sepsis rates when compared with transrectal prostate biopsy (TRPBx).^9,14
• Transperineal prostate biopsy provides greater sampling of the anterior prostate, an area of the gland that has previously been shown to give rise to more aggressive prostate cancer (PCa) clones.¹⁰
• The transperineal prostate biopsy approach, even with fusion or targeted biopsies, provides better detection of clinically significant disease, anterior tumours and fewer complications, than transrectal ultrasound (TRUS): it is a safer biopsy and better fit for a post-COVID future.^13,16
• Freehand transperineal prostate biopsy allows greater control of the needle trajectory and reduced unnecessary sampling of the transition zone.¹² 
• Freehand transperineal prostate biopsy enables easy integration of transperineal biopsy into a normal outpatient clinic workflow.¹¹
• Studies demonstrate freehand transperineal prostate biopsy may be performed in the office under local anesthesia without sedation.¹¹
• Other transperineal approaches often use a higher degree of anesthesia, unique equipment not routinely available, additional personnel and more time than the traditional transrectal approach.⁵
• The freehand transperineal technique can also be performed safely within a similar timeframe as allocated for the transrectal technique with a lower incidence of infection and hospitalization.⁴
• European professional guideline recommendations state freehand transperineal prostate biopsy technique eliminates the need for a pre-biopsy rectal swab.¹⁵
• The transperineal approach significantly reduces post-biopsy complications without quinolone antibiotics, especially urosepsis, while achieving an acceptable cancer detection rate (CDR) which preserves diagnostic sensitivity compared to TRUSBx.¹⁷